|
2023
|
Invention
|
Method for triethylenetetramine purification. Methods for the purification of impure triethylenet... |
|
|
Invention
|
Method for triethylenetetramine purification.
Methods for the purification of impure triethylene... |
|
|
Invention
|
Treatment of brain copper disorders.
The present disclosure relates to the treatment and prevent... |
|
2022
|
Invention
|
Treatment of copper disorders. The present disclosure relates to compositions comprising fixed do... |
|
|
Invention
|
Prevention and treatment of coronavirus and related respiratory infections.
The present disclosu... |
|
|
Invention
|
Treatment of copper disorder.
The present disclosure relates to compositions comprising fixed do... |
|
2020
|
Invention
|
Combination treatments for central nervous system disorders.
The inventions relate to compositio... |
|
|
Invention
|
Combination treatments for central nervous system disorders. The inventions relate to composition... |
|
|
Invention
|
Combination treatments for central nervous system disorders. 55 levels, including in Alzheimer's ... |
|
2019
|
Invention
|
Dosage forms and related therapies. This invention is directed in part to novel doses, dosage for... |
|
|
Invention
|
Synthesis of triethylenetetramines. Methods and intermediates for synthesizing triethylenetetrami... |
|
2017
|
Invention
|
Synthesis of triethylenetetramines.
Methods and intermediates for synthesizing triethylenetetram... |
|
2014
|
Invention
|
Treatment of mitochondria-related diseases and improvement of age-related metabolic deficits.
Ph... |
|
2013
|
Invention
|
Preventing and/or treating cardiovascular disease and/or associated heart failure. Methods are pr... |
|
2008
|
Invention
|
Adiponectin and uses thereof. The invention provides methods and reagents for regulation of metab... |
|
2007
|
Invention
|
Treatment of diabetes with copper binding compounds. Novel methods of treating a patient for dise... |
|
2006
|
Invention
|
Treatment of mitochondria-related diseases and improvement of age-related metabolic deficits.
Tr... |
|
|
Invention
|
Treatment of mitochondria-related diseases and improvement of age-related metabolic deficits. Tre... |
|
|
Invention
|
Copper regulation evaluation and therapy.
Assays methods for clinical evaluation of conditions t... |
|
|
Invention
|
Copper regulation evaluation and therapy. Assays methods for clinical evaluation of conditions th... |
|
2003
|
Invention
|
Dosage forms and related therapies.
This invention is directed in part to novel doses, dosage fo... |
|
|
Invention
|
Composition comprising triethylenetramine salts for treating tissue damage. This invention is dir... |
|
|
Invention
|
Use of copper chelating tetraamines for the treatment of cardiovascular disease and heart failure... |
|
2002
|
Invention
|
Fructosamine oxidase: antagonists and inhibitors. The present invention relates to methods of tre... |
|
2001
|
Invention
|
Fructosamine oxidase assay: methods and materials. Methods whereby, by reference to fructosamine ... |
